they receive biologic therapy.
With local centers across the country, Ulcerative Colitis patients requiring ongoing biologic infusions or injections relax in privacy and comfort during treatment.
Redefine your care experience
Guaranteed for all patients, with leather recliners and chairs for guests
On Your Schedule
Local centers offer flexible scheduling, including evenings and weekends
Greeted by name at check-in, patient suites are always ready when you arrive
Sit Back and Relax
Cable TV, Netflix, and more so you can catch up on your favorite shows
What is Ulcerative Colitis?
Our Ulcerative Colitis Formulary
Ulcerative Colitis Resources
The Crohn’s & Colitis Foundation is a non-profit, volunteer-fueled organization dedicated to finding cures for Crohn’s disease and ulcerative colitis, and improving the quality of life of children and adults affected by these diseases.
With the growing cost of care – especially for specialty pharmaceuticals like biologics – combined with new health plans designed to shift more of the financial responsibility to patients, every penny counts. Worrying about covering healthcare costs shouldn’t be at the forefront of anyone’s thoughts. Fortunately, there are a number of non-profit organizations and drug manufacturers that provide patient assistance programs (PAPs) to help shoulder some – and sometimes even all – of the financial burden.
As patients navigate the day-to-day of chronic disease management, it can be difficult to track medication, manage symptoms, and receive the support they need to live a healthy and fulfilled life. Fortunately, several companies took note and introduced apps to help patients understand, manage and provide insights into their condition.
A high number of medications for complex chronic conditions such as Crohn’s disease, rheumatoid arthritis, multiple sclerosis (MS), and many others are being administered by intravenous infusion. These sets of modern therapies provide patients with comprehensive and innovative treatment options, but they still have to make one critical decision – where to receive their infusion.